Search results for "Heart Valve"

showing 10 items of 138 documents

Focus on the unique mechanisms involved in thoracic aortic aneurysm formation in bicuspid aortic valve versus tricuspid aortic valve patients: clinic…

2013

OBJECTIVES: The involvement of different factors in the onset of thoracic aortic aneurysm (TAA) in patients with a bicuspid aortic valve (BAV) vs those with a tricuspid aortic valve (TAV) is well recognized. However, the molecular, genetic and cellular mechanisms driving TAA remain unclear. The aim of this study was to identify the different mechanisms involved in TAA development in patients with BAV vs TAV. METHODS: Aorta specimens and DNA samples were collected from 24 BAV (18 men and 6 women; mean age: 54.2 ± 14.39 years) and 110 TAV (79 men and 31 women, mean age: 66 ± 9.8 years) patients. A control group of 128 subjects (61 men and 67 woman, mean age: 61.1 ± 5.8 years) was also enrolle…

Aortic valveMaleThoracicHeart Valve DiseasesApoptosisPilot ProjectsBicuspid aortic valve; Clinical implications; Identifying different genetic and histological profiles; Thoracic aortic aneurysm; Tricuspid aortic valve; Adult; Aged; Aortic Aneurysm Thoracic; Aortic Valve; Apoptosis; Comorbidity; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heart Valve Diseases; Histocytochemistry; Humans; Male; Matrix Metalloproteinase 9; Middle Aged; Pilot Projects; Polymorphism Single Nucleotide; Risk Factors; Tricuspid ValveComorbidityBicuspid aortic valveBicuspid Aortic Valve DiseaseGene FrequencyFibrosisRisk FactorsClinical implicationsTricuspid valvebiologyHistocytochemistryGeneral MedicineSingle NucleotideMiddle AgedAortic Aneurysmmedicine.anatomical_structureMatrix Metalloproteinase 9Aortic ValveCardiologyFemaleTricuspid ValveCardiology and Cardiovascular MedicinePulmonary and Respiratory MedicineAdultmedicine.medical_specialtyBicuspid aortic valveGenotypeThoracic aortic aneurysmTricuspid aortic valvePolymorphism Single Nucleotidemedicine.arteryInternal medicineThoracic aortic aneurysmAscending aortamedicineSettore MED/05 - Patologia ClinicaHumansGenetic Predisposition to DiseasePolymorphismIdentifying different genetic and histological profilesAgedAortaAortic Aneurysm Thoracicbusiness.industryAngiotensin-converting enzymeSettore MED/23 - Chirurgia Cardiacamedicine.diseasebiology.proteinSurgerybusinessEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aorti…

2016

Aims Our aim was to assess the clinical outcomes of the Direct Flow Medical Transcatheter Aortic Valve System (DFM-TAVS), when used in routine clinical practice. Methods and results This is a prospective, open-label, multicentre, post-market registry of patients treated with DFM-TAVS according to approved commercial indications. Echocardiographic and angiographic data were evaluated by an independent core laboratory and adverse events were adjudicated and classified according to VARC-2 criteria by an independent clinical events committee. The primary endpoint was freedom from all-cause mortality at 30 days post procedure. Secondary endpoints included procedural, early safety and efficacy en…

Aortic valveMalemedicine.medical_specialtyCardiac Catheterizationmedicine.medical_treatmentAortic Valve InsufficiencyRegurgitation (circulation)030204 cardiovascular system & hematologyTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineClinical endpointHumans030212 general & internal medicineHeart valveProspective StudiesRegistriesCardiac catheterizationAgedAged 80 and overHeart Valve Prosthesis Implantationbusiness.industryAortic Valve Stenosismedicine.disease3. Good healthClinical trialStenosismedicine.anatomical_structureTreatment OutcomeAortic valve stenosisAortic ValveHeart Valve ProsthesisCardiologyFemaleCardiology and Cardiovascular MedicinebusinessEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
researchProduct

Difference in hemodynamic and wall stress of ascending thoracic aortic aneurysms with bicuspid and tricuspid aortic valve.

2012

The aortic dissection (AoD) of an ascending thoracic aortic aneurysm (ATAA) initiates when the hemodynamic loads exerted on the aneurysmal wall overcome the adhesive forces holding the elastic layers together. Parallel coupled, two-way fluid–structure interaction (FSI) analyses were performed on patient-specific ATAAs obtained from patients with either bicuspid aortic valve (BAV) or tricuspid aortic valve (TAV) to evaluate hemodynamic predictors and wall stresses imparting aneurysm enlargement and AoD. Results showed a left-handed circumferential flow with slower-moving helical pattern in the aneurysm's center for BAV ATAAs whereas a slight deviation of the blood flow toward the anterolater…

Aortic valveMalemedicine.medical_specialtyFluid–structure interaction Aortic dissection Ascending thoracic aortic aneurysm Bicuspid aortic valveBiomedical EngineeringBiophysicsHeart Valve DiseasesAorta ThoracicThoracic aortic aneurysmArticleAortic aneurysmBicuspid aortic valveBicuspid Aortic Valve DiseaseInternal medicinemedicine.arteryCoronary CirculationAscending aortamedicineThoracic aortaHumansOrthopedics and Sports Medicinecardiovascular diseasesAgedAortic dissectionAortabusiness.industryRehabilitationHemodynamicsModels CardiovascularMiddle Agedmedicine.diseaseElasticityAortic Aneurysmmedicine.anatomical_structureAortic ValveCardiologycardiovascular systemFemaleTricuspid ValvebusinessJournal of biomechanics
researchProduct

Value and limitations of transesophageal echocardiography in the evaluation of aortic prostheses.

1993

Results of 34 transesophageal (TEE) studies in patients with suspected aortic prosthetic dysfunction were compared with transthoracic echocardiographic (TTE) results and to anatomic findings. Mass lesions noted at surgery (autopsy) were correctly described in 93% by TEE versus 43% by TTE. Abscesses were detected in 88% by TEE versus 18% by TTE. Bioprosthetic degeneration was visualized in 88% versus 38% and prosthetic obstruction correctly identified in 75% versus 50% by TEE and TTE, respectively. Anatomic aortic regurgitant lesions were identified in 96% by TEE versus 77% by TTE, whereas the correct origin was detected in 88% of cases by TEE versus 54% of cases by TTE. TEE provides valuabl…

Aortic valveMalemedicine.medical_specialtyProsthesis-Related InfectionsAortic Valve InsufficiencyAutopsySensitivity and SpecificityPostoperative ComplicationsPredictive Value of TestsmedicineHumansRadiology Nuclear Medicine and imagingIn patientProspective StudiesBioprosthesisbusiness.industryThrombosisbody regionsmedicine.anatomical_structureEchocardiographyAortic ValveHeart Valve ProsthesisFemaleRadiologyCardiology and Cardiovascular Medicinebusinesshuman activitiesJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
researchProduct

Transcatheter Heart Valve Implantation in Bicuspid Patients with Self-Expanding Device

2021

Bicuspid aortic valve (BAV) patients are conventionally not treated by transcathether aortic valve implantation (TAVI) because of anatomic constraint with unfavorable outcome. Patient-specific numerical simulation of TAVI in BAV may predict important clinical insights to assess the conformability of the transcathether heart valves (THV) implanted on the aortic root of members of this challenging patient population. We aimed to develop a computational approach and virtually simulate TAVI in a group of n.6 stenotic BAV patients using the self-expanding Evolut Pro THV. Specifically, the structural mechanics were evaluated by a finite-element model to estimate the deformed THV configuration in …

Aortic valveTechnologymedicine.medical_specialtybicuspid aortic valveQH301-705.5medicine.medical_treatment0206 medical engineeringDiastoleBioengineering02 engineering and technology030204 cardiovascular system & hematologyBicuspid aortic valve Finite-element analysis Fluid–solid interaction Transcatheter aortic valve implantationArticle03 medical and health sciences0302 clinical medicineBicuspid aortic valveInternal medicinemedicine.arterymedicineCardiac skeletonHeart valveBiology (General)transcatheter aortic valve implantationAortabusiness.industryTSettore ING-IND/34 - Bioingegneria IndustrialeStentmedicine.diseasefluid–solid interaction020601 biomedical engineeringAortic wallmedicine.anatomical_structurefinite-element analysiscardiovascular systemCardiologybusinessBioengineering
researchProduct

Chronic atrial fibrillation in presence of aortic stenosis in a patient with polysplenia syndrome.

2013

We report a rare case of “situs viscerum ambiguous” with polysplenia syndrome, in a 69 year old female patient with aortic stenosis and chronic atrial fibrillation. The presenting symptom was dyspnoea on moderate exertion and an ECG showed supra ventricular arrhythmia. Patients trans-thoracic echocardiogram revealed a dilated left atrium, reduced ejection fraction, mild tricuspid regurgitation, moderate-severe pulmonary hypertension and severe aortic stenosis. The patient was successfully treated with a replacement of her aortic valve and ascending aorta.

Aortic valvemedicine.medical_specialtyPolysplenia syndromeRegurgitation (circulation)Heterotaxy SyndromePolysplenia Aortic Stenosis Atrial Fibrillationmedicine.arteryInternal medicineAscending aortaAtrial FibrillationMedicineChronic atrial fibrillationHumanscardiovascular diseasesAortaAgedHeart Valve Prosthesis ImplantationEjection fractionbusiness.industryGeneral MedicineAortic Valve Stenosismedicine.diseasePulmonary hypertensionSettore MED/11 - Malattie Dell'Apparato CardiovascolareStenosismedicine.anatomical_structureTreatment OutcomeChronic Diseasecardiovascular systemCardiologyFemalebusinessActa clinica Belgica
researchProduct

Effect of Physiologic Oscillatory Fluid Shear Stress on Engineered Heart Valve Tissue Formation.

2010

It was previously demonstrated that combined flexure and flow in vitro conditioning augments engineered heart valve tissue formation using bone marrow-derived mesenchymal stem cells (MSC) seeded on polyglycolic acid (PGA)/poly-L-lactic acid (PLLA) blend nonwoven fibrous scaffolds (Engelmayr, et al., Biomaterials 2006; vol. 27 pp. 6083-95). Additionally, seeded scaffolds incorporated into a tissue engineered valve construct experienced significant increases in tissue formation rates with media supplementation (basic fibroblast growth factor [bFGF] and ascorbic acid-2-phosphate [AA2P]) and dynamic conditioning approximating pulmonary valve levels (Ramaswamy, et al., Biomaterials 2010; vol. 31…

Bioreactor heart valves oscillatory flow mechanical stimuli mesenchymal stem cells
researchProduct

Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis

2000

Inflammatory cytokines such as interleukin-1 (IL-1) and tumour necrosis factor-alpha (TNF-alpha), as well as shear stress, cause endothelial cells (ECs), to undergo not only functional alterations but also structural reorganizations, which contribute to vascular leakage. Like ECs of the human aorta, ECs on heart valves are exposed to extreme shear stress. However, while ECs expression of cell adhesion molecules (CAMs) in large vessels has been widely studied, it seems that there are no such studies on ECs of heart valves, although this knowledge might be important for our understanding of the aetiological aspects of local inflammatory responses. Using immunohistochemistry, this study charac…

CD31Aortic valvePathologymedicine.medical_specialtyHeart diseaseBiologymedicine.diseasePathology and Forensic MedicineEndothelial activationEndothelial stem cellchemistry.chemical_compoundmedicine.anatomical_structurechemistrymedicineEndocarditisHeart valveVCAM-1The Journal of Pathology
researchProduct

Computed tomography imaging needs for novel transcatheter tricuspid valve repair and replacement therapies

2020

Abstract Transcatheter tricuspid valve therapies are an emerging field in structural heart interventions due to the rising number of patients with severe tricuspid regurgitation and the high risk for surgical treatment. Computed tomography (CT) allows exact measurements of the annular plane, evaluation of adjacent structures, assessment of the access route, and can also be used to identify optimal fluoroscopic projection planes to enhance periprocedural imaging. This review provides an overview of current transcatheter tricuspid valve repair and replacement therapies and to what extent CT can support these interventions.

Cardiac Catheterizationmedicine.medical_specialtyComputed tomographyRegurgitation (circulation)030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineTricuspid Valve InsufficiencyMedical imagingHumansMedicineRadiology Nuclear Medicine and imagingcardiovascular diseases030212 general & internal medicineTRICUSPID VALVE REPAIRSurgical treatmentHeart Valve Prosthesis ImplantationTricuspid valveAccess routemedicine.diagnostic_testbusiness.industryGeneral MedicineTricuspid Valve InsufficiencyTreatment Outcomemedicine.anatomical_structureHeart Valve Prosthesiscardiovascular systemTricuspid ValveRadiologyTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal - Cardiovascular Imaging
researchProduct

Centre procedural volume and adverse in‐hospital outcomes in patients undergoing percutaneous transvenous edge‐to‐edge mitral valve repair usingMitra…

2021

AIMS The number of transcatheter mitral valve repair (TMVr) procedures has increased substantially during the last years. A better understanding of the relationship between hospital volume of transcatheter transvenous mitral valve repairs using MitraClip® and patient outcomes may provide information for future policy decisions to improve patient management. METHODS AND RESULTS We analysed patient characteristics and in-hospital outcomes for all TMVr procedures using MitraClip® performed in Germany from 2011 to 2017. Hospitals were stratified according to centre volumes and patients were compared for baseline characteristics and adverse in-hospital events. Overall, 24 709 inpatients were tre…

Cardiac Catheterizationmedicine.medical_specialtyPercutaneousmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineGermanyMitral valvemedicineHumansHeart FailureHeart Valve Prosthesis ImplantationMitral regurgitationMitral valve repairbusiness.industryMitraClipMitral Valve InsufficiencyOdds ratiomedicine.diseaseHospitalsConfidence intervalSurgeryPulmonary embolismTreatment Outcomemedicine.anatomical_structureHeart Valve ProsthesisMitral ValveCardiology and Cardiovascular MedicinebusinessEuropean Journal of Heart Failure
researchProduct